{"url_path":"/sec/vxrt/8-k/2026-07-02/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/72444/0001213900-26-074576-index.html","accession_number":"0001213900-26-074576","cik":"0000072444","ticker":"VXRT","issuer_name":"Vaxart, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/72444/0001213900-26-074576-index.html","primary_entity_key":"0000072444","primary_entity_name":"Vaxart, Inc."},"word_count":140,"has_tables":true,"body_markdown":"**Item 7.01 Regulation FD Disclosure.**\n\n \n\nOn July 1, 2026, the Company issued a press release announcing the\nmatters addressed above. A copy of the press release is furnished with this report as Exhibit 99.1.\n\n \n\nThe information in this Current Report on Form 8-K under Item 7.01\nand Exhibit 99.1 attached hereto is being furnished to the Securities and Exchange Commission and shall not be deemed to be “filed”\nfor purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to\nthe liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company’s filings with the Securities\nand Exchange Commission under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific\nreference in such a filing."}